CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Young Min Cho, Rhonda D. Wideman, Timothy J. Kieffer
Endocrinol Metab. 2013;28(4):262-274.   Published online December 12, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.4.262

Excel Download

Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Endocrinology and Metabolism. 2013;28(4):262   Crossref logo
Link1 Link2 Link3

Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists
Clinical Therapeutics. 2015;37(3):483-493   Crossref logo
Link1 Link2

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Diabetes mellitus. 2017;20(4):286-298   Crossref logo
Link1 Link2

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
The Journal of Korean Diabetes. 2018;19(1):35   Crossref logo
Link1 Link2 Link3

Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Clinical Therapeutics. 2017;39(6):1244-1264   Crossref logo
Link1 Link2

Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review
Diabetes Research and Clinical Practice. 2019;149:78-88   Crossref logo
Link1 Link2

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Diabetes mellitus. 2018;21(4):293-300   Crossref logo
Link1 Link2

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2020;   Crossref logo
Link1 Link2

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2019;   Crossref logo
Link1 Link2

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2019;   Crossref logo
Link1 Link2